XML 44 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Discontinued Operations and Divestiture - Schedule of Significant Non-cash Items and Capital Expenditures for Discontinued Operations (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 29, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Depreciation       $ 713 $ 2,312
Investment income in unconsolidated variable interest entity       (2,485) (2,664)
Gain on divestiture       (52,163) 0
Impairment of property and equipment       2,062 0
Dividend received from unconsolidated variable interest entity       3,947 2,230
Stock-based compensation       5,387 25,037
FibroGen International [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Depreciation       713 1,117
Investment income in unconsolidated variable interest entity       (2,485) (2,664)
Gain on divestiture $ (52,200) $ (52,163) $ 0 (52,163) 0
Impairment of property and equipment       2,062 0
Dividend received from unconsolidated variable interest entity       3,947 2,230
Stock-based compensation       $ 231 $ 1,326